The Department for Environment, Food & Rural Affairs (Defra) has launched a consultation on reforming the governance arrangements of the RCVS.
The consultation follows a period of discussions between the RCVS and Defra about how the College might best modernise Council.
The consultation gives the public and profession the opportunity to have their say on what reforms would best prepare the College for the future. It discusses the appropriate size and composition of Council, including the proportion of elected members, how veterinary schools should be represented, increasing lay membership, and ensuring appropriate veterinary nurse representation. It also examines how flexibility can be built into the reforms in case of future changes, such as the possibility of new categories of associate. Responses to the consultation will inform the College’s work with Defra to determine the precise details of any new governance arrangements.
The College says any reform should meet its unique requirements as a Royal College that regulates and the criteria already agreed by the College: Council’s decision-making role would be strengthened, for instance, by increasing the number of Council meetings per year. This would reduce or remove the need for a separate Operational Board in order that the CEO reports directly to Council.
Any reforms also need to ensure that Council has sufficient members to populate the College’s committees and Presidential team, and follow the government’s five principles of better regulation, by being proportionate, consistent, accountable, transparent and targeted.
RCVS President Bradley Viner (pictured top right) said “I am delighted that Defra is consulting on RCVS governance and the minister has the full backing of RCVS Council in so doing. This consultation is an opportunity to hear the voice of the profession and the public about an appropriate structure and oversight of the RCVS, reflecting the uniqueness of being a Royal College that regulates. Consulting on this important issue is in keeping with our desire to become first rate in what we do, building on other measures to modernise and improve the workings of the College.”
Dr. Lauren Finka, a researcher at the University of Lincoln, has developed L-CAT, a new tool for assessing behaviour in cats at rehoming centres and help match them to the ideal new home.
During the course of her PhD studies, which were part funded by COAPE (Centre of Applied Pet Ethology), Lauren discovered inconsistencies in the current models and perceptions of behaviour traits used in re-homing cats.
For example, one of the most common behaviours associated with affection towards humans is the activity of rubbing. Initial results suggested that this is often very inconsistent, as are several other behaviours that were previously thought to to be important in assessing a cat's underlying temperament. Dr Finka’s studies showed that it all depends much more on the specifics of the physical and social context of interactions and that these may change on a daily basis. It was found that on one day a cat might rub against a person ten times, but the next day rub against the same person only once.
The Lincoln Cat Assessment Tool (L-CAT) was developed during this research. COAPE says it is the first of its kind to offer a suitably robust, reliable and easy-to-use way of assessing behaviour in cats at re-homing centres, as well in predicting new owner satisfaction based on those assessments.
The organisation goes on to say that the potential welfare implications of this research are substantial, enabling cats to be properly but rapidly assessed, optimally managed, and suitably matched with would-be owners and thus shortening the length of time cats might spend in the re-homing centre.
L-CAT was tested to establish the possibility of predicting the future behaviour of cats after they had been adopted, as well as gauging how satisfied owners were likely to be with their cats. COAPE says the results generally confirmed that these outcomes were indeed possible, meaning re-homing staff could also use L-CAT to help manage the expectations of owners and potentially improve their satisfaction.
For more information, visit: www.coape.org
The industry-led Cattle Health and Welfare Group of Great Britain (CHAWG) has published a review which identifies a practical approach to gathering antibiotic usage data on UK cattle farms.
The review outcomes, announced today at a joint conference held by the Responsible Use of Medicines in Agriculture Alliance (RUMA) and the Veterinary Medicines Directorate (VMD), highlight the significant benefits better data could deliver, such as improving the way antibiotics are administered strategically to tackle disease.
But CHAWG’s chair Tim Brigstocke says it’s also important that the industry is able to accurately report usage levels because of the rising levels of antibiotic-resistant bacteria which threaten human health.
"We found that while data is already stored at every vet practice and in every farm medicine book, it currently exists in many different forms. It’s also not collected or collated, and is further complicated by multi-species approvals for many of the antibiotics.
"This means we can’t always be sure in which type of animal a medicine has been used. For example, out of 420 tonnes of animal-authorised antibiotic active substance sold in the UK in 2013, only 14 tonnes was authorised solely for use in cattle. However, 63 tonnes was authorised for multi-species use in food producing animals and within the 217 products included in this, 201 are authorised for use in cattle."
Tim says that with the support of the VMD, which requested the review and will now act as secretariat, CHAWG will set up a working group to implement the report’s recommendations.
The starting point is likely to be the survey of vets carried out by the British Cattle Veterinary Association (BCVA), which formed part of the review. This suggested vets could be using as many as 15 different software programmes to log data, so CHAWG will be working with the BCVA and individual practices to look at how standard sets of data can be anonymised and exported.
"Then we will almost certainly look at how cattle farmers can be supported in migrating records from the physical ‘medicine book’ on the farm, into a spreadsheet or existing cattle management software for anonymous aggregation on a national level.
"There are undoubtedly areas where we can improve the effectiveness of how we use these powerful medicines to improve welfare. But the antibiotic resistance debate is an emotive one and we must also demonstrate accountability to ensure the preservation of antibiotics for future use in humans and animals; any future curbs on usage should be proportionate and informed, and not compromise animal wellbeing."
Mandatory reporting in Europe could be just over the horizon and the European Medicines Agency has focused in the past year on developing a method for data collection on the usage of antibiotics in the EU pig sector. In the UK, the VMD is encouraging the livestock sectors to develop systems appropriate to their own unique circumstances and industry characteristics.
Tim said: "It’s therefore in cattle farmers’ own interests to anticipate the kind of figures it might be asked to supply in the future, and develop a way of collecting that data which suits the way the UK industry works.
"Then we can retain control over the data and the methodology, and ensure the reporting is accurate – and this in turn will help the VMD represent our case better in Europe as this debate continues.
CHAWG says that throughout this project, it will be liaising with others – such as the pig sector – to ensure learnings are shared, duplication avoided and efficiencies realised where possible.
The CHAWG review report is available to download at www.chawg.org.uk.
The Westpoint Group has announced the divestiture of its small animal and equine veterinary practices in order to focus on production animal health and welfare.
From now, the production animal business - which includes veterinary practices providing services to pig, poultry, dairy, beef, sheep, game bird producers and small holders - will be known under the umbrella brand of Origin.
The company says that excellence and innovation in client service will continue to be the focus throughout the organisation.
Matt Dobbs, Managing Director of Origin said: "Origin is committed to supporting livestock farmers to enhance production by improving health and welfare. We have a unique group of vets, researchers, lab techs and paraprofessionals passionate about the success of UK agriculture, with other businesses committed to supporting the industry, joining us through the autumn.
"By focusing on supporting farmers, we will become a unique source of animal insight in livestock agriculture."
For more information, visit: http://www.westpointveterinarygroup.com
Petplan has announced a new category - ‘Rising Star’ - has been added to its 2016 Veterinary Awards.
The company says its awards, which recognise members of the veterinary profession who have gone above and beyond in their daily roles, have been focussed on established individuals. The idea behind the new award is to recognise someone that is rising within their current practice, showing great aptitude and who has substantially grown in their role within a relatively short period of time.
The award is geared towards employees with less than two years’ experience, who have initiated, coordinated and accomplished a new or improved activity or process during 2015. Petplan says nominees should also show one or more of the following ‘Four C’s’ in their initiative: compassion, competence, communication and commitment.
James Barnes, Head of Sales and Partnerships at Petplan, said: “Petplan understands the importance of committed veterinary staff in ensuring pet safety and care. Working with almost 5,000 vet practices, we see the fantastic work being carried out across the country and these awards are an opportunity for pet owners to say a heartfelt ‘thank you’ for the support veterinary staff provide to the animals in their care.”
To nominate a colleague for an award, visit www.petplanvet.co.uk/vetawards before 31st January 2016.
London Vet Specialists (LVS), billed as the capital's first complete-service referral centre, has announced its official opening in Belsize Park.
The centre is headed up by senior surgeon and soft tissue specialist, Dr Janet Kovak McClaran DVM DACVS DECVS MRCVS, former head of the department of surgery at the Animal Medical Center in New York.
Janet leads a team of consultants specialising in internal medicine and surgery, diagnostic imaging, emergency and critical care, anaesthesia and analgesia, and minimally-invasive surgery.
Janet says the new centre was set up to enable London-based vets to access close-by expert help across key areas: "When I was first approached about setting up a referral centre servicing central and greater London, I was surprised that a dedicated facility didn’t already exist. Previously, referring clinicians have had to send clients on long journeys outside of the capital, leading to patient stress and hassle and extra expense for the owners. Now, they have the reassurance of access to a highly-experienced secondary and tertiary level referral team on their doorstep."
The LVS facility boasts a state-of-the-art surgical theatre, complete with a Karl Storz operating tower enabling cutting-edge laparoscopic, thoracoscopic and cystoscopic procedures. The minimally-invasive surgery suite is one of only three such facilities in the UK. An onsite CT scanner, the GE Brivio CT 385, forms part of an array of imaging equipment, operated by European Specialist in Veterinary Diagnostic Imaging, Dr Livia Benigni. The immediate interpretation of even the most-complex of images is designed to allow seamless patient investigation and negate the need for repeated patient anaesthetics.
Internal Medicine consultant Dr Kaye Gugich, formerly of Vets Now Referrals in Swindon, together with board-certified Emergency and Critical Care Specialist Dr Adam Mugford, and Dr Karla Borland, a previous resident in anaesthesia and analgesia at Edinburgh University, complete the consultant team.
London Vet Specialists says it is the only facility in central London to offer a full time specialist surgery service alongside a specialist service in emergency and critical care. Emergency stabilisation and intensive care is available around the clock, with experienced clinicians and a nursing team ensuring continuous supervision, day or night. The LVS specialist surgical team is also on call to the hospital overnight should specialist emergency surgery be required out of hours.
Patient and customer care at LVS is based on the model used by Sydney’s SASH Vets (Small Animal Specialist Hospital). LVS Client Relations Manager Claire Newton helped to develop the SASH system during her time at the advanced referral hospital, which concentrates on delivering the highest standards of patient care, alongside a dedicated support system for the client and referring vet.
Claire said: "From the very start of the referral process, customer care is prioritised. In this we consider that we have two customers; the first, the referring vet, who needs to feel that he or she has an integral role in the ongoing management of the case, and that his or her client is well-looked after. Our second customer, the pet owner or client, needs to be looked after with compassion and respect, and have the ability to speak directly to the clinician in charge of their pet, at any point. Excellent two-way communication is key. We ensure that we listen and respond to the needs of both parties through every step of the customer journey."
For more information on London Vet Specialists, or to speak to Claire Newton about referring a patient, visit www.londonvetspecialists.vet, email Claire.newton@londonvetspecialists.vet, or telephone 0207 4330155.
Merial has published Give Them Just What they Need, a guide to the key considerations concerning the vaccination of cats.
The company says it produced the guide after conducting research in which 76% of small animal veterinary surgeons said they are not fully aware of the most recent feline vaccination guidelines, and 98% said they'd find a guide useful.
The survey1, which was conducted amongst 114 UK small animal vets, also showed that whilst 82% of vets are aware of the existence of feline vaccination guidelines from organisations such as the World Small Animal Veterinary Association (WSAVA) and European Advisory Board on Cat Diseases (ABCD), 58% don’t know the content well, and a further 18% were not aware of the guidelines at all.
In a concurrent survey of 1000 cat owners2, 60% said they would have more confidence in their vet knowing that they were vaccinating according to the latest guidelines. The cat owner survey also found that 80% rely on their vet for information about vaccination, and 60% would like more information about vaccination.
Claire Edmunds, product manager at Merial, said: "Understanding that vets are busy people and using all of the insight that we have gathered from vets and owners to shape the content of the guide, we have condensed previously published vaccination recommendations from organisations such as WSAVA and ABCD into really useful, practical advice. The new guide and complementary support materials will hopefully prove to be really valuable resources for vets, giving them the information they need when reviewing their vaccination protocols, in a quick, easy-access format.
"By being better informed about the latest recommendations, we want vets to feel more confident in discussing all aspects of vaccination with their clients. With the majority of cat owners saying that they rely on their vet for vaccination information and nearly half stating that their vet clearly explaining the benefits of vaccination would increase their compliance in vaccinating their cat, this obviously will be beneficial to both the practice and pet cats."
Merial has also produced supporting materials for use alongside the guide, including a take-home leaflet for owners and digital assets for social media and newsletter use, designed to help vets start discussions about vaccination.
Give Them Just What they Need is available from your regional Merial Territory Manager or for download at https://goo.gl/7Uas3y
References
Boehringer Ingelheim has launched Bitesize (www.bi-bitesize.co.uk), an educational website about canine epilepsy for veterinary surgeons.
Boehringer’s Brand Manager Craig Roxburgh said: "We have teamed up with eight neurology experts working in referral centres across the UK. These experts have covered the questions most commonly encountered when managing epilepsy cases in first opinion practice, which we hope will assist vets in their epilepsy case management."
Answers to questions are delivered as short video clips of between one and three minutes, optimised for use on smartphones and tablet devices to make them available in the practice or on the move.
Craig added: "Canine epilepsy can be a complex condition to manage. We hope therefore that when cases present, Bitesize will prove a useful and handy ‘go-to’ resource for vets to access information at the time they need it."
There's a chance to win an iPad if you visit the new site before 29th February 2016.
Barrettine Environmental Health has launched MiteMax, a new treatment for poultry red mite (PRM) with a physical mode of action.
Charles Phillips from Barratine said: "PRM poses a significant threat to laying hens particularly, with infestation costing the UK egg industry in excess of an estimated €3 million per annum through PRM control and lost production. In the UK, PRM is prevalent in varying percentages according to the rearing system used. Caged birds are estimated to have a variable 7.5 to 87.5 % prevalence. Free range systems are estimated to have 60 % prevalence of PRM, with organic systems higher at 78 %. Less intensive systems have a greater prevalence of PRM due to the higher number of cracks and crevices associated with a more enriched environment1."
MiteMax is applied directly to a shed’s inner surfaces via knapsack sprayer, rendering the surfaces sticky and permanently immobilising red mites that come into contact with them.
According to the company, the new product - which is designed to fit into and encourage integrated pest management practices - provides rapid knock-down of poultry red mite.
Charles added: "The physical mode of action of MiteMax makes it effective against pesticide-resistant mites. MiteMax is specifically formulated to penetrate surface dust making it highly effective at reaching mites harbouring deep in crevices."
In conjunction with robust cleansing practices, Ian Whelan an expert in physical insect control techniques says MiteMax fits neatly into an integrated pest management style of husbandry: "Using treatments with different modes of action together as part of a flock health plan ensures each one fulfils its potential."
MiteMax is available nationwide from Barrettine Environmental Health's appointed distributors.
Reference
Zoetis has announced that it has upscaled production of Apoquel, the oral therapy for the treatment of canine pruritus, and it is now available to all UK vet practices on unlimited distribution.
The company says that there was unprecedented demand for Apoquel following its launch last year, so it had to introduce an allocation system to ensure that those dogs that had started on the product were able to remain on it for as long as their vet deemed appropriate.
During this time, Zoetis focused on strengthening its manufacturing capacity to make the product more widely available.
Apoquel is the first Janus Kinase (JAK) inhibitor approved for veterinary use. Zoetis says it provides rapid and sustained relief of pruritus and improves skin lesions. Its novel mechanism of action on the JAK enzyme is specifically designed to target the pruritogenic and pro-inflammatory pathways involved in the itch cycle. This, says the company, allows effective reduction of allergic itch regardless of its cause as well as improvement of skin lesions associated with allergic skin diseases and atopic dermatitis.
Ned Flaxman, companion animal business unit director at Zoetis said: “We are very grateful to all our veterinary customers for bearing with us through this product shortage. Over the past 18 months we have incorporated a variety of safeguards to ensure that Apoquel supply will better align with demand. We have reduced the length of time it takes to manufacture Apoquel and added further production capacity.
“It’s been a very long 18 months for everyone involved but we’re looking forward to a very good Christmas and New Year with Apoquel fully back in stock and we’d like to thank all of our customers for their patience.”
For more information, visit www.zoetis.co.uk/apoquel.
The Evidence-Based Veterinary Medicine Learning Consortium has announced the launch of a new online tutorial (www.ebvmlearning.org) designed to make evidence-based veterinary medicine (EBVM) accessible to the veterinary profession worldwide.
The online tutorial, funded by the RCVS Knowledge Target Grants initiative and led by Dr Kristen Reyher at the University of Bristol along with Drs Rachel Dean and Marnie Brennan from the Centre for Evidence-based Veterinary Medicine at the University of Nottingham, begins with an introductory module and then focuses on the five key areas of EBVM:
The learning resource, which can be used on various platforms and devices, is suitable for students and practitioners for self-study, and can be used as a stand-alone tutorial or as individual teaching modules to support other EBVM teaching or continuing professional development.
The online tutorial uses best educational practice and includes formative multiple choice questions, short tasks and recommendations for further study. It is intended to be a source of knowledge, bringing together the essentials of EBVM into one place, and highlights many other links to resources and organisations that are available to further learners’ knowledge about the subject.
Dr Kristen Reyher, Senior Lecturer in Farm Animal Science in the School of Veterinary Sciences, who led the project team, said: "It is hoped that the development of this resource will increase awareness of EBVM in the veterinary profession, and allow practitioners the opportunity to develop the skills needed to utilise EBVM in everyday clinical practice."
Future aims of the project team include designing methods of cataloguing and disseminating evidence synthesis to support clinical decision-making and evidence-based veterinary practice, improving and standardising the teaching of EBVM to undergraduate and postgraduate students at veterinary schools internationally, and building a community of practice in this area.
Zoetis has announced the launch of Ketavet.
The intravenous anaesthetic solution containing ketamine is available in 10ml and 50ml presentations. The new product coincides with the re-classification of ketamine as a schedule 2 drug.
Ketavet is a clear, colourless solution for injection containing ketamine 100 mg/ml (equivalent to 115.36 mg/ml ketamine hydrochloride) with benzethonium chloride 0.1 mg/ml as a preservative. It can be used to induce anaesthesia in horses in conjunction with xylazine, detomidine or romifidine.
Ketavet, along with other ketamine containing products, has been moved to Schedule 2 of the Misuse of Drugs Regulations, which took effect from 30 November 2015. This enables tighter controls on the record keeping, prescribing and safe custody of products containing this active. More information on the specific requirements which will need to be met following the schedule change can be found on the VMD website https://www.gov.uk/government/news/amendments-to-the-misuse-of-drugs-regulations-2001
Penny McCann, Equine Product Manager at Zoetis said: "Ketavet is an important product in our anaesthesia portfolio. We are keen to help veterinary surgeons keep up-to-date with the reclassification of ketamine and with this in mind our new product packaging clearly reflects ketamine’s revised status as a schedule 2 drug."
For more information, contact your Zoetis Account Manager.
Animalcare has launched Vetaclean, a new range of disinfectants which the company says has a notably high kill activity against canine parvovirus and common feline viruses such as FIV, FeLV and FCV.
The range comprises Vetaclean Parvo Advance, a surface disinfectant-cleaner, Vetaclean enzymatic instrument detergent-cleaner, and an instrument disinfectant.
Animalcare Product Manager, Tony Liepman, said: "Veterinary nurses tell us that canine parvovirus is the most challenging and resistant pathogen they work with, and so we set this as our benchmark for the Vetaclean disinfectant products. Tested under EN protocols and having 99.99% + kill activity against parvovirus, our new disinfectants demonstrate high efficacy against a broad range of bacteria, including MRSA/MRSP, fungi, viruses, mycobacteria and spores.
"Infection control is in the spotlight at the moment, highlighted by initiatives from within and outside our industry. Firstly, the new Practice Standards Scheme - launched at the same time as our range - places great emphasis on having a rigorous biosecurity policy. This includes requirements for personal hygiene as well as cleanliness of premises and equipment. High-level decontamination of instruments and equipment is ensured through the Vetaclean two-stage process, which works with even soiled instruments or equipment, and in under 20 minutes. The products have also been designed to be suitable for use on the most specialised equipment seen in today’s practices, including flexible or rigid endoscopes, ultrasonic baths, aspirators, arthroscopes and re-processing machines.
"Importantly, the active ingredients in the Vetaclean range meet the criteria of the new EU Biocides Regulations, policed by the Health and Safety Executive in the UK, which came into effect on 1st September 2015. All products with biocidal activity now need to undergo a complex registration process, ensuring the products are not harmful to people, the environment or animals. The rigorous process may see many disinfectant manufacturers pull out of the market, resulting in less choice. Further, the Vetaclean range does not contain Poly (hexamethylene biguanide) hydrochloride (PHMB). The European Chemicals Agency (ECHA) is currently proposing that PHMB is listed as a category 2 carcinogen."
The Vetaclean Parvo Advance range includes a 1 litre lavender product in a self-dosing bottle, 5 litre apple and lemon-fragranced liquid concentrates and unfragranced large surface wipes. There are two different dilution rates: a general purpose dilution rate for most pathogens at 1:100 (10ml per litre), and a parvocidal dilution rate at 1:50 (20ml per litre). Animalcare says the alkaline-based formula ensures that the products are compatible with a wide range of materials and are non-staining. Both the enzymatic instrument cleaner and instrument disinfectant are available in 2 litre concentrates (incorporating a calibrated dosing reservoir).
The Vetaclean range is available now in wholesalers. The company has also produced a brochure Hygiene in practice, a guide to veterinary infection control from Animalcare, designed to help familiarise veterinary professionals with the principles and uses of the product range. There is also a special launch offer of Buy-4-Get-One-Free available from Animalcare representatives.
For further information, contact Animalcare on 01904 487687, or speak to your regional Animalcare representative: www.animalcare.co.uk/contact-us.
The BVA and the RCVS are inviting applications from veterinary surgeons to join the new Vet Futures Action Group, set up to drive forward the ambitions identified in the Vet Futures report launched at BVA Congress at the London Vet Show on 20 November.
The Vet Futures report, Taking charge of our future: A vision for the veterinary profession for 2030, was the culmination of a year-long joint project by BVA and RCVS designed to help the veterinary profession prepare for, and shape, its own future. The Action Group is a vital next step in the Vet Futures project, ensuring the delivery of the report’s six ambitions and 34 recommendations.
BVA and RCVS are seeking seven veterinary surgeons and one veterinary nurse to join the Action Group to ensure there is buy-in from across the professions and to drive forward workstreams of activity. The group will be co-chaired by the BVA and RCVS Presidents, and both Junior Vice-Presidents will sit on the group. Action Group members will be independent and will not represent, or be required to report back to, any particular organisation.
Veterinary surgeons or nurses keen to apply for an Action Group role should have experience of working as an active member of a group or committee and the ability to deliver, engage and inspire others. The veterinary surgeon members should have specific expertise, knowledge and experience in relation to at least one of the Vet Futures ambitions or the cross-cutting issue of veterinary education. The ambitions cover:
Successful applicants must be able to attend three all-day meetings in London (9 February, 17 March and 12 May) and an all-day Vet Futures Summit (20 June), with a time commitment totalling approximately seven days between February and June 2016. The group will be supported by BVA and RCVS staff. For the full Vet Futures Action Group role profile and terms of reference, please visit: www.vetfutures.org.uk.
The deadline for applications is 12 noon, 31 December 2015.
Pets’n’Vets has announced that it is burying a veterinary time capsule under its new Roundhouse Veterinary Hospital being built on the southside of Glasgow.
Brainchild of Pets’n’Vets partner Ross Allan, the idea is that the capsule will reveal to future generations how the cutting edge veterinary facility in Glasgow looked in 2015 and help show just how far veterinary science has developed when it is opened in 2115.
Ross said: "The aim of the time capsule is to document the memories, hopes and dreams of our staff at this exciting point in our story, and preserve them as best we can for discovery in 100 years."
The capsule, which was curated with help from The Veterinary History Society and the British Library, contains:
Ross said: "As an orthopaedic surgeon, I’m used to dealing with cutting edge metal plates, screws and pins when fixing fractured legs, but helping develop this capsule was an entirely new challenge for me. It is very rewarding to use great science to preserve these memories as best we can.
"The time capsule has been designed with this in mind: maintaining optimal humidity, zero oxygen and steady temperature. It will be welded shut before being flushed with argon gas, all measures to help preserve the photos, letters and other contents for those that are lucky enough to open it."
In order preserve the contents as best as possible, Ross sought the advice of Glasgow Museums, which advised including archive quality paper and ink to prevent fading of writing and images, as well as the use of corrosion bags to contain the metallic surgical implants.
"I thought it would be fun to include the implants we currently use for cruciate surgery," said Ross. "This is one aspect of veterinary surgery that has especially progressed over the last 30 years and will doubtlessly continue to progress in the years ahead."
David Thomson, Preventative Conservation Officer, Glasgow Museums, added: "Sending things safely into the future is very like preserving the collections we have in the Museum. The Veterinary Time Capsule meets the highest standards for slowing down the normal ageing effects of our environment and we wish it well on its journey through time."
The time capsule has been registered with the International Time Capsule Society (ITCS) at Oglethorpe University, Atlanta, USA.
Ross said: "This will ensure the capsule is followed up and not, like the majority, lost forever," said Ross. "When opened, the contents should offer a snapshot into Scottish 21st Century veterinary medicine and perhaps it can offer a small legacy to the future of veterinary medicine too.
"Veterinary medicine is going through a huge transition at present – the scope of what is available today is poles apart from what was possible even 10 years ago – and we are delighted to help document its development in Glasgow to this point. Just what might be possible when the capsule is opened in 2115 is mind boggling!"
5m Books has announced the publication of Honeybee Veterinary Medicine: Apis Mellifera L. by Nicolas Vidal-Naquet, a new book written to help veterinary surgeons and veterinary students better understand how to preserve honeybees as part of a delicate ecosystem.
Honeybee Veterinary Medicine provides an overview of bee biology, the bee in the wider environment, bee diseases and parasites, veterinary treatment, and actions to help support honeybee health.
Honeybees are an essential part of farming and the wider ecosystem, but since the mid-1990s, bee populations around the world have suffered a dramatic decline through a combination of diseases, intoxication, and unknown causes.
5m says that with the depopulation trend continuing, it’s becoming more and more necessary for veterinary surgeons and qualified animal health professionals to become involved in supporting the ecosystem.
Author Nicolas Vidal-Naquet is a veterinary practitioner who graduated in apiculture and Honeybee medicine, and also lectures on honeybee biology and diseases at the Veterinary School of Alfort in France.
Nicolas’ great interest in honeybees was the driving force behind the book, but he is also concerned by the general loss of bees from the ecosystem. He said: "They have a very important role in the pollination of wild flora, crops and orchards, which means they are key actors in sustaining biodiversity and the pollination of crops to feed both humans and animals."
Honeybee Veterinary Medicine is available now in hardback for £60 from http://www.5mbooks.com/honeybee-veterinary-medicine.html
Macahl Animal Health, a new veterinary company which took over the manufacture and distribution of Oralade in the summer, is to make its first appearance at the London Vet Show later this month.
The company will be highlighting its Feed Don’t Fast campaign designed to encourage veterinary professionals to take a much more proactive approach to the early feeding of patients to improve patient outcomes.
Macahl Director Anthony Mackle said, “The Feed Don’t Fast campaign is gathering momentum. We’ve been encouraged by the feedback we’ve had from veterinary practices starting to look at the nutritional needs of their in-patients much earlier than they did before. Rather than waiting to see if a patient will eat or not, they are starting to be more nutritionally-aware, and prioritising feeding in the same way that they prioritise the administration of clinical care or medication. The case studies we’ve received show a clear benefit in early nutrition assisting recovery.
“But we don’t want to sit back and wait for the message to make its own way round: it’s an urgent need. We have to flip the notion of delaying feeding or fasting patients until the gut settles down or they have recovered from whatever condition they were admitted for. Science has moved on. The protocols for human patients recommend early intervention with appropriate nutrition and we need to get this message out to give the same benefits to our pet patients. This is why the educational message of Feed Don’t Fast is so important.”
Macahl says it is making education a key feature of its stand at London Vet Show with technical updates on early feeding of patients and the opportunity to sign up for nutrition and critical care feeding webinars. Staff will be on hand to explain the benefits of early day 1 microenteral feeding to help with the optimal functioning of the gut, and maintenance of the gut-associated lymphoid barrier. The company will be offering a special buy-two-get-one-free LVS promotion on its leading microenteral and rehydration product, Oralade, as well as giving away free dog- and cat-shaped ice cube trays to encourage practice staff to freeze left-over product for further use.
A new website, www.oralade.com will also be launched at London Vet Show which will allow veterinary professionals to access educational materials and videos, and sign up for new and recent webinars.
For more information, visit: www.feeddontfast.co.uk or telephone Macahl Animal Health on (0)28 8778 9245
Royal Canin has announced a new Approved Weight Management Centre programme for vet practices across the UK.
As part of the programme, a number of practices across the UK will receive ‘Centre of Excellence’ status for managing overweight or obese cats and dogs educating clients on prevention.
To gain approved centre status, practices are required to establish a formal Weight Management Clinic and work as a team to refer clients with overweight pets through the clinic. The chosen practices will receive bespoke training from a member of the Weight Management Team, to provide them with the skills and protocols to discuss obesity with clients and encouraging vets, nurses and receptionists to work together to raise awareness of obesity.
Shelley Holden from the Weight Management Team said: "This is a unique platform for practices across the UK to take advantage of and really excel in addressing weight management issues in practice and tackling prevention. We are excited to currently work with an elite group of practices, all committed to raising awareness of obesity in cats and dogs."
Royal Canin has so far given nine clinics 'Centre of Excellence' status. They all now discuss body condition scoring with patients to identify whether the pet is in ideal condition. If overweight or obese, they are then referred for further advice and support to their weight clinic. The weight clinic is a complimentary 30 minute appointment with a weight management nurse, followed by ongoing monitoring, personalised advice and telephone support. Approved clinics also educate owners about prevention during puppy parties, puppy and kitten vaccinations, and at neutering to ensure owners are aware of the health risks of weight gain from the outset.
Jo Hammett BVSc MRCVS, Owner of The Stocks Vets (pictured right), said: "We have received bespoke training from Royal Canin to achieve centre status, giving our team the confidence to discuss the sensitive issues surrounding weight with clients, in addition to tackling education. This has really helped break down barriers in approaching the topic with clients about their pets’ weight and we are finding they are now much more open with the team during consultations, which is a major achievement in itself."
For more information about the Approved Weight Management Centre programme, contact your veterinary business manager or visit www.royalcanin.co.uk.
The Bella Moss Foundation (BMF) and Oncore Online Learning have announced the launch of a 2 week online training course developed to help veterinary professionals implement rigorous, tailored infection controls in practice.
Practical Infection Control is delivered online as a fully tutored course and students will have access to Oncore's virtual learning environment which will host a lecture, learning materials and discussion forums.
Course materials and ongoing tutor support and assessment will be provided by VN lecturer and BMF advisor Louise O'Dwyer. As part of the course, students will be able to create and implement their own tailored infection control standard operating procedures for their practice, which will be evaluated by Louise.
Course registration is now open, and as soon as a minimum of eight students are booked, the first two week course will go live. Practical Infection Control costs £129 and counts for six hours of documented CPD. A percentage of the proceeds will be donated to BMF, to help the charity continue to fund veterinary education and support for pet owners seeking advice on antimicrobial resistant infections.
Louise O’Dwyer said: "This will be a highly interactive course which will be tailored to the individual delegate, and therefore the individual practices. "It will have a different learning format to many other CPD courses, being interactive and very much driven by delegate feedback, meaning those undertaking the course can gain the specific information they need on aspects such as prevention of surgical site infections, cleaning and disinfection, surgical patient preparation and hand hygiene." Jill Macdonald, RVN and founder of ONCORE Online Learning, said: "Infection control is a key component of any practice routine, but in my experience having clear and up-to-date practice guidelines and protocols – that everyone actually uses – can sometimes be overlooked.
"This module, especially timely given new official focus on infection safeguards in the PSS, will empower nurses and other staff to implement the most recent and robust infection control methods, whatever their place of work, whether it be a small local practice or a large veterinary hospital."
To register for Practical Infection Control or find out more about the range of courses offered by ONCORE, visit www.oncoreepd.co.uk or contact info@oncoreepd.co.uk or 07717 335484 To find out more about BMF, visit: www.thebellamossfoundation.com
SPVS has announced that Professor Noel Fitzpatrick will appear ‘In Conversation’ with Martin Whiting, lecturer in ethics at the RVC, at the SPVS/VPMA Congress at the Celtic Manor Resort on 29/30th January 2016.
Noel is both an inspirational and a controversial figure. Few would question that his orthopaedic and neurology work has been both brilliant and life saving. Anyone close to him will tell you he is a dedicated workaholic who believes passionately in the sanctity of life.
However, some would argue that programmes like the BBC’s Bionic Vet and Channel 4’s Super Vet may raise expectations among pet owners as to what the average vet practice can do. And then there's the question of just how far practitioners should go to save / prolong an animal's life. Just because you can, does it mean you should?
These are the areas that will be explored in this hour long ‘conversation’ in a format borrowed from literary festivals. There will be an opportunity for the audience to submit their questions from the floor.
For further details and to to book, visit www.spvs-vpma-events.co.uk or call 01453 872731.
Amy Bergs MRCVS, owner of The Cat Doctor in Surrey and co-founder of the new British Mobile Veterinary Association, has won a week's worth of free advertising for her practice on national TV.
The competition was run by the mobile payments company iZettle, which invited entrants to submit a 15 minute video about their business.
Amy's husband and business partner Robert put the video entry together. It was one of seven winners picked out of hundreds that iZettle said it received.
The resulting advert (below) is being shown on a number of TV channels, including Sky News, Sky Sports and Comedy Central, from today.
Amy said: "We are so excited to have won the competition. We love what we do and would like to help more cats, it’s such an amazing opportunity to share what we can offer on national television!"
watch?v=Vi8SCWcPJoo
Vetcel, the veterinary buying group, has announced a partnership with Training Progress, through which it will deliver its health and safety training information to member practices.
Training Progress is a training management system designed primarily so that veterinary managers can track their staff training. The company says the system empowers staff to drive their own training, and devolves training responsibility (where appropriate) away from senior team members.
The tie-up with Vetcel means member practices will be able to access Vetcel's health and safety training in their own own mini Training-Progress site, where they will be able to track their teams' progress and compliance.
Chris Bainton said: "The Vetcel group are delighted to be working with Training-Progress to provide a further benefit to our membership. We recognise that Training-Progress will help our members ensure that their team’s staff development and training is promoted and, specifically, that both the staff and the practices themselves are protected and enabled by monitoring and recording the health and safety training of the team.”
Training Progress will be at stand O54 at the London Vet Show.
Leading human and animal health organisations – the British Medical Association (BMA), British Dental Association (BDA), British Veterinary Association (BVA) and Royal Pharmaceutical Society (RPS) - have joined forces for the first time to promote a ‘One Health’ approach to ensure responsible guardianship of antibiotics and their proper public use on European Antibiotics Awareness Day tomorrow.
Antibiotics are obviously a vital medicine for both animal and human health, and modern health systems rely on the availability and effectiveness of a range of antimicrobials to treat and prevent infections. Yet inappropriate use – such as prescribing for self-limiting infections, not finishing a prescribed course of antibiotics or habitual prophylactic use in healthy animals to prevent disease - all contribute to the development of resistant bacteria in both humans and animals.
Whilst antibiotic resistance in animals does not perhaps present the greatest immediate existential threat, there is a strong argument for a united message to the public coming from doctors, dentists, chemists and veterinary surgeons.
Quite simply, some 13M households own a pet. Pretty much all of them visit a vet at some stage, and most will be a human patient at some point in their lives. So, what a veterinary surgeon says about the use of antibiotics in animals has the potential to help transform how owners think about them when they come to visit the doctor.
A survey of general practitioner doctors last year found that 90% feel pressured by patients to prescribe antibiotics and 28% have prescribed them several times a week when not sure they are medically necessary. If veterinary surgeons refuse to prescribe them for pets unless medically necessary, explaining that they are a precious resource which can no longer be wasted, it could help relieve the pressure on doctors. The same goes for the importance of compliance; if owners learn the importance of their pet taking the full course, there's a greater chance they'll understand why they need to complete their own course of treatment.
BVA President Sean Wensley said: "Antimicrobial resistance (AMR) is too important an issue for uncoordinated approaches amongst the medical professions. We need to work together to share knowledge and successful approaches, as well as taking responsibility for not just the immediate clinical situations before us, but also for our role in supporting the health and wellbeing of wider society. An effective approach to tackling AMR is about professions and patients working together for the greater good."
BMA board of science Chair Professor Sheila the Baroness Hollins said: "Doctors have expressed significant concern about the threat of a ‘post-antimicrobial age’. It is vital that we see action to improve antimicrobial prescribing across all disciplines. Only by different professionals working together to improve antimicrobial stewardship will we start to address this major public health issue."
BDA President Professor Nairn Wilson said: "All health professionals have a responsibility to draw a line under inappropriate or unnecessary use of antibiotics. One in ten prescriptions in the UK are provided by dentists, so we’re determined to do our bit. We are facing a clear and present danger to public health, and it will only be overcome if we act together."
For further information about EAAD 2015, visit www.ecdc.europa.eu/en/EAAD
To mark EAAD 2015, BVA has produced a range of new posters to promote the responsible use of antibiotics for use in veterinary practices or as a source of information for pet owners which can be found on their website www.bva.co.uk/eaad.
Zoetis has announced that the European Commission has granted marketing authorization for Simparica™ (sarolaner) chewable tablets, a once-monthly medication for the treatment of fleas, ticks and sarcoptic mange in dogs beginning at eight weeks of age.
Dr. Balázs Capári, a Hungarian veterinary specialist in small animal medicine who participated in clinical trials of Simparica said: "The approval of Simparica gives veterinarians a new oral choice in parasite control for dogs. In my experience, Simparica has been shown to rapidly kill fleas and ticks with efficacy that persists for five weeks. Dog owners participating in the trials also reported that Simparica is very palatable; the chewable tablet was easily taken by their dogs. The convenience of a once monthly chewable tablet helps increase compliance with treatment, giving veterinarians and dog owners confidence in continuous protection."
Dr. Catherine Knupp, Executive Vice President and President, Research and Development at Zoetis, said: "At Zoetis, we focus our innovation on the most pressing needs of veterinarians, and that is what guided us to develop a new oral choice to provide dogs with persistent protection from fleas and ticks and treatment of mites that cause sarcoptic mange. Simparica is a result of the collaboration of Zoetis scientists worldwide, who share a determination to develop new medicines that deliver real value to our veterinary customers and the animals in their care. We are excited to bring this innovative medicine, Simparica, to veterinarians and dog owners across Europe."
The active substance of Simparica is sarolaner, a new ectoparasiticide in the isoxazoline class, developed by Zoetis.
Zoetis says the marketing authorization for Simparica was based on the results of field studies conducted in seven countries, involving more than 800 dogs of various breeds from at least eight weeks of age and 1.3 kg of weight. Simparica was shown to provide efficacy for at least five weeks against ticks and fleas. It demonstrated a rapid onset of action, killing fleas before they have a chance to lay eggs and can be used as part of a treatment strategy for the control of Flea Allergy Dermatitis. It proved effective in treating sarcoptic mange, a highly contagious skin disease in dogs.
In studies, Simparica killed all four species of tick dominant in Europe (Dermacentor reticulatus, Ixodes hexagonus, Ixodes ricinus and Rhipicephalus sanguineus) and species of flea that most frequently infect dogs in European countries (Ctenocephalides felis and Ctenocephalides canis). Simparica was well tolerated with no adverse events reported at the therapeutic dose.
Zoetis expects to launch Simparica in the EU in the first quarter of 2016. Simparica chewable tablets will be available in 5mg, 10mg, 20mg, 40mg and 80mg dosage strengths.
For more information about Simparica and full prescribing information, visit http://www.zoetis.com/products-services/companion-animals/dogs.
The Equine Veterinary Journal (EVJ) has published a free online collection of articles which explain the current understanding of equine antimicrobial resistance and how the profession can preserve the effectiveness of these essential medicines.
The new collection comprises ten clinical reports and studies and three editorials covering current trends on bacterial populations, risk factors and the appropriate use of antimicrobials in practice.
A clinical report on the changes in bacterial populations in foals with sepsis raises the question whether the emergence of resistance in horses has occurred as a result of antibiotic use in humans, with nosocomial spread from human handlers in foals. Studies on the prevalence of faecal carriage of antimicrobial resistant E. coli show their prevalence to be common in normal horses in the community in the UK, although MRSA carriage was rare. Data suggested transmission of resistant bacteria from animals receiving antibiotics may result in carriage of bacteria by in contact animals.
The need for judicious use of antimicrobials is reinforced in a study on antimicrobial-associated diarrhoea in three equine referral practices. Two papers investigate both prescribing practice in the UK and the impact of antimicrobial use on infection and pyrexia in hospitalised horses, concluding that there are opportunities for more targeted, ‘smart’, use antimicrobials in the perioperative period, rather than simply more antimicrobials.
The final study discusses a low-cost syndromic surveillance model for monitoring healthcare associated infection in clinical practice to provide a realistic benchmark against which other hospitals may compare antimicrobial study data.
Three supporting editorials complete the online collection, giving comment on the overall situation of antimicrobial resistance in the horses, including the current political situation and antimicrobials and surgical site infection.
Professor Peter Clegg, Associate Editor of the Equine Veterinary Journal said: "It remains to be determined how big a problem antimicrobial resistance will become for the equine veterinary profession, either through greater difficulties in treating horses, or through political pressure to restrict access to antimicrobials. Meanwhile the EVJ remains committed to the promotion of responsible stewardship to best preserve the efficacy of the drugs we have got for as long as we can."
Mark Bowen, President of the British Equine Veterinary Association and guest editor said: "BEVA has a long-term commitment to promoting responsible antimicrobial use throughout the profession and supporting EAAD through the PROTECT ME brand. This year we have released resources around Education, aimed at the profession through EVJ and to the horse owning public through development of material that can be provided alongside antimicrobial dispensing. The work of the equine profession in preserving the highest priority antimicrobials will ensure efficacy can be retained for as long as is possible."
The antimicrobial online collection is available free online at: http://onlinelibrary.wiley.com/journal/10.1001/(ISSN)2042-3306/homepage/antimicrobial_resistance.htm